[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![RedChip Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::25292321.png) RedChip [@RedChip](/creator/twitter/RedChip) on x 5578 followers
Created: 2025-07-09 13:34:18 UTC

🔬 bioAffinity Technologies $BIAF: CyPath® Lung Detects Early-Stage Cancer Where Imaging Fell Short

A new case study highlights CyPath® Lung's potential to change lung cancer diagnostics. The noninvasive test identified Stage 1A adenocarcinoma in a high-risk patient whose CT and PET scans showed inconclusive or low-probability results.

💡 Why This Matters to Investors:
- Proven Clinical Impact: Detected cancer in a case where standard imaging failed, allowing for early surgical intervention and likely saving a life.
- Cost-Saving Potential: Peer-reviewed analysis estimates up to $370M in Medicare savings annually using CyPath® Lung.
- Market Access: Covered by Medicare and commercial insurers, and available via the Federal Supply Schedule for veterans and military.

📄 Read the full news:

@bioAffinity $BIAF $AZN $KURA $TMO $PHG


XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1942940378019057839/c:line.svg)

**Related Topics**
[scans](/topic/scans)
[$biaf](/topic/$biaf)

[Post Link](https://x.com/RedChip/status/1942940378019057839)